The FDA’s hostility toward both supplements and compounded medicine is legendary—after all, they compete with the FDA-approved drugs that pay the government’s bills. Now the agency is attacking compounded supplements. Action Alert!
A few weeks ago, we reported on an amendment designed to fix a number of the most problematic regulations arising from Congress’s Drug Quality and Security Act (DQSA). The amendment would clarify provisions governing “office use,” allowing physicians to keep certain quantities of compounded drugs on hand in their office, and also remove the cap on interstate shipments if the medication is for an individual patient. ANH-USA strongly supports this amendment, as it would ensure patient access to important compounded medications which are currently endangered.
READ COMPLETE ARTICLE AND TAKE ACTION